1-9 of 9
Manuel Salto-Tellez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer

Sudhir B. Malla, David J. Fisher, Enric Domingo, Andrew Blake, Sylvana Hassanieh, Keara L. Redmond, Susan D. Richman, Michael Youdell, Steven M. Walker, Gemma E. Logan, Aikaterina Chatzipli, Raheleh Amirkhah, Matthew P. Humphries, Stephanie G. Craig, Ultan McDermott, Matthew T. Seymour, Dion G. Morton, Philip Quirke, Nicholas P. West, Manuel Salto-Tellez, Richard D. Kennedy, Patrick G. Johnston, Ian Tomlinson, Viktor H. Koelzer, Letitia Campo, Richard S. Kaplan, Daniel B. Longley, Mark Lawler, Timothy S. Maughan, Louise C. Brown, Philip D. Dunne
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (1): 288–300.
https://doi.org/10.1158/1078-0432.CCR-20-3237
Published: 04 January 2021
View article titled, In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer
Open the PDF for In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer

Manuela Salvucci, Maximilian L. Würstle, Clare Morgan, Sarah Curry, Mattia Cremona, Andreas U. Lindner, Orna Bacon, Alexa J. Resler, Áine C. Murphy, Robert O'Byrne, Lorna Flanagan, Sonali Dasgupta, Nadege Rice, Camilla Pilati, Elisabeth Zink, Lisa M. Schöller, Sinead Toomey, Mark Lawler, Patrick G. Johnston, Richard Wilson, Sophie Camilleri-Broët, Manuel Salto-Tellez, Deborah A. McNamara, Elaine W. Kay, Pierre Laurent-Puig, Sandra Van Schaeybroeck, Bryan T. Hennessy, Daniel B. Longley, Markus Rehm, Jochen H.M. Prehn
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (5): 1200–1212.
https://doi.org/10.1158/1078-0432.CCR-16-1084
Published: 28 February 2017
View article titled, A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer
Open the PDF for A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer

Philip D. Dunne, Darragh G. McArt, Conor A. Bradley, Paul G. O'Reilly, Helen L. Barrett, Robert Cummins, Tony O'Grady, Ken Arthur, Maurice B. Loughrey, Wendy L. Allen, Simon S. McDade, David J. Waugh, Peter W. Hamilton, Daniel B. Longley, Elaine W. Kay, Patrick G. Johnston, Mark Lawler, Manuel Salto-Tellez, Sandra Van Schaeybroeck
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16): 4095–4104.
https://doi.org/10.1158/1078-0432.CCR-16-0032
Published: 14 August 2016
View article titled, Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer
Open the PDF for Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

Philip D. Dunne, Sonali Dasgupta, Jaine K. Blayney, Darragh G. McArt, Keara L. Redmond, Jessica-Anne Weir, Conor A. Bradley, Takehiko Sasazuki, Senji Shirasawa, Tingting Wang, Supriya Srivastava, Chee Wee Ong, Ken Arthur, Manuel Salto-Tellez, Richard H. Wilson, Patrick G. Johnston, Sandra Van Schaeybroeck
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 230–242.
https://doi.org/10.1158/1078-0432.CCR-15-0603
Published: 03 January 2016
View article titled, EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Open the PDF for EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Progressive loss of EGFR in a subpopulation of breast cancers: Implications in target-directed therapeutics

Lee Yee Choong, Simin Lim, Marie Chiew-Shia Loh, Xiaohui Man, Yunhao Chen, Weiyi Toy, Mengfei Pan, Chien-Shing Chen, Anuradha Poonepalli, M Prakash Hande, Puay Hoon Tan, Manuel Salto-Tellez, Chow-Yin Wong, Nilesh Shah, Brian J Druker, Yoon-Pin Lim
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): B33.
Published: 15 August 2014
View article titled, Progressive loss of EGFR in a subpopulation of breast cancers: Implications in target-directed therapeutics
Journal Articles

Epigenetic inactivation of RUNX3 in preneoplastic lesions of colorectum

Manish Subramaniam, Jason Chan, Richie Soong, Kosei Ito, Yeoh Khay Guan, Reuben Wong, Thomas Guenther, Olivia Will, Chee Leong Chen, Marian Kumarasinghe, Yoshiaki Ito, Manuel Salto-Tellez
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22_Supplement): B6.
Published: 15 August 2014
View article titled, Epigenetic inactivation of RUNX3 in preneoplastic lesions of colorectum
Journal Articles

AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer

Philip D. Dunne, Darragh G. McArt, Jaine K. Blayney, Murugan Kalimutho, Samanda Greer, Tingting Wang, Supriya Srivastava, Chee Wee Ong, Ken Arthur, Maurice Loughrey, Keara Redmond, Daniel B. Longley, Manuel Salto-Tellez, Patrick G. Johnston, Sandra Van Schaeybroeck
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (1): 164–175.
https://doi.org/10.1158/1078-0432.CCR-13-1354
Published: 05 January 2014
View article titled, AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
Open the PDF for AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer in another window
Includes: Supplementary data
Journal Articles

Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy

Clare McCourt, Pamela Maxwell, Roberta Mazzucchelli, Rodolfo Montironi, Marina Scarpelli, Manuel Salto-Tellez, Joe M. O'Sullivan, Daniel B. Longley, David J.J. Waugh
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (14): 3822–3833.
https://doi.org/10.1158/1078-0432.CCR-11-3277
Published: 15 July 2012
View article titled, Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy
Open the PDF for Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor–Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer

Wen-Son Hsieh, Ross Soo, Bee-Keow Peh, Thomas Loh, Difeng Dong, Donny Soh, Lim-Soon Wong, Simon Green, Judy Chiao, Chun-Ying Cui, Yoke-Fong Lai, Soo-Chin Lee, Benjamin Mow, Richie Soong, Manuel Salto-Tellez, Boon-Cher Goh
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1435–1442.
https://doi.org/10.1158/1078-0432.CCR-08-1748
Published: 19 February 2009
View article titled, Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer
Open the PDF for Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell Cycle Modulator, in Undifferentiated Nasopharyngeal Cancer in another window